Literature DB >> 19021304

Older patients' perceptions of medication importance and worth: an exploratory pilot study.

Denys T Lau1, Becky A Briesacher, Nathaniel D Mercaldo, Leslie Halpern, E Charles Osterberg, Mary Jarzebowski, June M McKoy, Kathleen Mazor.   

Abstract

BACKGROUND: Cost-related medication non-adherence may be influenced by patients' perceived importance of their medications.
OBJECTIVES: This exploratory pilot study addresses three related but distinct questions: Do patients perceive different levels of importance among their medications? What factors influence perceptions of medication importance? Is perceived importance associated with perceived worth of medications, and does expense impact on that association?
METHODS: Study participants included individuals aged >or=60 years who were taking three or more prescription drugs. Semi-structured, in-person interviews were conducted to measure how patients rated their medications in terms of importance, expense and worth. Factors that influenced medication importance were identified using qualitative analysis. Ordinal logistic regression analyses were employed to examine the association between perceived importance and perceived worth of medications, and the impact of expense on that association.
RESULTS: For 143 prescription drugs reported by 20 participants, the weighted mean rating of medication importance was 8.2 (SD 1.04) on a scale from 0 (not important at all) to 10 (most important). Patients considered 38% of these medications to be expensive. The weighted mean rating of worth was 8.4 (SD 1.46) on a scale from 0 (not worth it at all) to 10 (most worth). Three major factors influenced medication importance: drug-related (characteristics, indications, effects and alternatives); patient-related (knowledge, attitudes and health); and external (the media, healthcare and family caregivers, and peers). Regression analyses showed an association between perceived importance and perceived worth for inexpensive medications (odds ratio [OR] 2.23; p = 0.002) and an even greater association between perceived importance and perceived worth for expensive medications (OR 4.29; p < 0.001). DISCUSSION: This study provides preliminary evidence that elderly patients perceive different levels of importance for their medications based on factors beyond clinical efficacy. Their perception of importance influences how they perceive their medications' worth, especially for medications of high costs. Understanding how patients perceive medication importance may help in the development of interventions to reduce cost-related non-adherence.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19021304      PMCID: PMC2747735          DOI: 10.2165/0002512-200825120-00007

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  16 in total

1.  The effect of drug co-payments on utilization and cost of pharmaceuticals in a health maintenance organization.

Authors:  B L Harris; A Stergachis; L D Ried
Journal:  Med Care       Date:  1990-10       Impact factor: 2.983

2.  Adverse events associated with prescription drug cost-sharing among poor and elderly persons.

Authors:  R Tamblyn; R Laprise; J A Hanley; M Abrahamowicz; S Scott; N Mayo; J Hurley; R Grad; E Latimer; R Perreault; P McLeod; A Huang; P Larochelle; L Mallet
Journal:  JAMA       Date:  2001 Jan 24-31       Impact factor: 56.272

3.  The demand for prescription drugs as a function of cost-sharing.

Authors:  A Leibowitz; W G Manning; J P Newhouse
Journal:  Soc Sci Med       Date:  1985       Impact factor: 4.634

4.  Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey.

Authors:  David W Kaufman; Judith P Kelly; Lynn Rosenberg; Theresa E Anderson; Allen A Mitchell
Journal:  JAMA       Date:  2002-01-16       Impact factor: 56.272

5.  Cost-lowering strategies used by medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage.

Authors:  Chien-Wen Tseng; Robert H Brook; Emmett Keeler; W Neil Steers; Carol M Mangione
Journal:  JAMA       Date:  2004-08-25       Impact factor: 56.272

6.  Cost-related medication underuse among chronically ill adults: the treatments people forgo, how often, and who is at risk.

Authors:  John D Piette; Michele Heisler; Todd H Wagner
Journal:  Am J Public Health       Date:  2004-10       Impact factor: 9.308

7.  Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes.

Authors:  S B Soumerai; D Ross-Degnan; J Avorn; T j McLaughlin; I Choodnovskiy
Journal:  N Engl J Med       Date:  1991-10-10       Impact factor: 91.245

8.  Pharmacy benefits and the use of drugs by the chronically ill.

Authors:  Dana P Goldman; Geoffrey F Joyce; Jose J Escarce; Jennifer E Pace; Matthew D Solomon; Marianne Laouri; Pamela B Landsman; Steven M Teutsch
Journal:  JAMA       Date:  2004-05-19       Impact factor: 56.272

9.  The health effects of restricting prescription medication use because of cost.

Authors:  Michele Heisler; Kenneth M Langa; Elizabeth L Eby; A Mark Fendrick; Mohammed U Kabeto; John D Piette
Journal:  Med Care       Date:  2004-07       Impact factor: 2.983

10.  Self-restriction of medications due to cost in seniors without prescription coverage.

Authors:  M A Steinman; L P Sands; K E Covinsky
Journal:  J Gen Intern Med       Date:  2001-12       Impact factor: 5.128

View more
  12 in total

1.  Factors influencing cost-related nonadherence to medication in older adults: a conceptually based approach.

Authors:  Kara Zivin; Scott Ratliff; Michele M Heisler; Kenneth M Langa; John D Piette
Journal:  Value Health       Date:  2010-01-08       Impact factor: 5.725

2.  Patient beliefs and attitudes to taking statins: systematic review of qualitative studies.

Authors:  Angela Ju; Camilla S Hanson; Emily Banks; Rosemary Korda; Jonathan C Craig; Tim Usherwood; Peter MacDonald; Allison Tong
Journal:  Br J Gen Pract       Date:  2018-06       Impact factor: 5.386

3.  Discordance Between Drug Adherence as Reported by Patients and Drug Importance as Assessed by Physicians.

Authors:  Stéphanie Sidorkiewicz; Viet-Thi Tran; Cécile Cousyn; Elodie Perrodeau; Philippe Ravaud
Journal:  Ann Fam Med       Date:  2016-09       Impact factor: 5.166

4.  Individual patients hold different beliefs to prescription medications to which they persist vs nonpersist and persist vs nonfulfill.

Authors:  Colleen A McHorney; Abhijit S Gadkari
Journal:  Patient Prefer Adherence       Date:  2010-07-21       Impact factor: 2.711

5.  Medication adherence and use of generic drug therapies.

Authors:  Becky A Briesacher; Susan E Andrade; Hassan Fouayzi; K Arnold Chan
Journal:  Am J Manag Care       Date:  2009-07       Impact factor: 2.229

6.  Deprescribing medication in very elderly patients with multimorbidity: the view of Dutch GPs. A qualitative study.

Authors:  Jan Schuling; Henkjan Gebben; Leonardus Johannes Gerardus Veehof; Flora Marcia Haaijer-Ruskamp
Journal:  BMC Fam Pract       Date:  2012-07-09       Impact factor: 2.497

7.  Testimonials and Informational Videos on Branded Prescription Drug Websites: Experimental Study to Assess Influence on Consumer Knowledge and Perceptions.

Authors:  Helen W Sullivan; Amie C O'Donoghue; Jennifer Gard Read; Jacqueline B Amoozegar; Kathryn J Aikin; Douglas J Rupert
Journal:  J Med Internet Res       Date:  2018-01-23       Impact factor: 5.428

8.  Barriers and enablers for deprescribing among older, multimorbid patients with polypharmacy: an explorative study from Switzerland.

Authors:  Stefan Zechmann; Cosima Trueb; Fabio Valeri; Sven Streit; Oliver Senn; Stefan Neuner-Jehle
Journal:  BMC Fam Pract       Date:  2019-05-14       Impact factor: 2.497

9.  Older people's attitudes towards deprescribing cardiometabolic medication.

Authors:  Stijn Crutzen; Jamila Abou; Sanne E Smits; Gert Baas; Jacqueline G Hugtenburg; Mette Heringa; Petra Denig; Katja Taxis
Journal:  BMC Geriatr       Date:  2021-06-16       Impact factor: 3.921

10.  Regimen complexity and medication nonadherence in elderly patients.

Authors:  Andrea Corsonello; Claudio Pedone; Fabrizia Lattanzio; Maria Lucchetti; Sabrina Garasto; Claudia Carbone; Cosetta Greco; Paolo Fabbietti; Raffaele Antonelli Incalzi
Journal:  Ther Clin Risk Manag       Date:  2009-03-26       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.